3D QSAR comparative molecular field analysis on nonsteroidal farnesoid X receptor activators
- 31 March 2007
- journal article
- research article
- Published by Elsevier in Journal of Molecular Graphics and Modelling
- Vol. 25 (6) , 921-927
- https://doi.org/10.1016/j.jmgm.2006.09.003
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Potential therapeutic applications of farnesoid X receptor (FXR) modulatorsExpert Opinion on Therapeutic Patents, 2006
- LXRS AND FXR: The Yin and Yang of Cholesterol and Fat MetabolismAnnual Review of Physiology, 2006
- The Farnesoid X ReceptorArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- Farnesoid X Receptor: From Structure to Potential Clinical ApplicationsJournal of Medicinal Chemistry, 2005
- Potential regulatory role of the farnesoid X receptor in the metabolic syndromeBiochimie, 2004
- The Farnesoid X Receptor (FXR) as Modulator of Bile Acid MetabolismReviews in Endocrine and Metabolic Disorders, 2004
- Principles for modulation of the nuclear receptor superfamilyNature Reviews Drug Discovery, 2004
- Discovery of novel nuclear receptor modulating ligands: an integral role for peptide interaction profilingDrug Discovery Today, 2004
- 6α-Ethyl-Chenodeoxycholic Acid (6-ECDCA), a Potent and Selective FXR Agonist Endowed with Anticholestatic ActivityJournal of Medicinal Chemistry, 2002
- Identification of a Chemical Tool for the Orphan Nuclear Receptor FXRJournal of Medicinal Chemistry, 2000